FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

4153711000001104: Octreotide 30mg powder and solvent for suspension for injection vials 1 vial (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21856901000001110 Octreotide 30mg powder and solvent for suspension for injection vials 1 vial (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21857001000001114 Octreotide 30mg powder and solvent for suspension for injection vials 1 vial en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


2 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Octreotide 30mg powder and solvent for suspension for injection vials 1 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Octreotide 30mg powder and solvent for suspension for injection vials 1 vial Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Octreotide 30mg powder and solvent for suspension for injection vials 1 vial Is pack of Octreotide 30mg powder and solvent for injection suspension vial false Inferred relationship Existential restriction modifier
Octreotide 30mg powder and solvent for suspension for injection vials 1 vial Has active ingredient Somatostatin false Inferred relationship Existential restriction modifier
Octreotide 30mg powder and solvent for suspension for injection vials 1 vial Has active ingredient Octreotide false Inferred relationship Existential restriction modifier
Octreotide 30mg powder and solvent for suspension for injection vials 1 vial Has active ingredient Octreotide acetate false Inferred relationship Existential restriction modifier
Octreotide 30mg powder and solvent for suspension for injection vials 1 vial Has active ingredient Synthetic hormone agent false Inferred relationship Existential restriction modifier
Octreotide 30mg powder and solvent for suspension for injection vials 1 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Octreotide 30mg powder and solvent for suspension for injection vials 1 vial VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Octreotide 30mg powder and solvent for suspension for injection vials 1 vial Has manufactured dose form Powder for conventional release suspension for injection false Inferred relationship Existential restriction modifier
Octreotide 30mg powder and solvent for suspension for injection vials 1 vial Has VMP Octreotide 30mg powder and solvent for injection suspension vial false Inferred relationship Existential restriction modifier
Octreotide 30mg powder and solvent for suspension for injection vials 1 vial Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Octreotide true Inferred relationship Existential restriction modifier
Octreotide 30mg powder and solvent for suspension for injection vials 1 vial Has specific active ingredient Octreotide acetate true Inferred relationship Existential restriction modifier
Octreotide 30mg powder and solvent for suspension for injection vials 1 vial Has dispensed dose form Powder and solvent for suspension for injection true Inferred relationship Existential restriction modifier
Octreotide 30mg powder and solvent for suspension for injection vials 1 vial Has basis of strength substance Octreotide true Inferred relationship Existential restriction modifier
Octreotide 30mg powder and solvent for suspension for injection vials 1 vial Has VMP Octreotide 30mg powder and solvent for suspension for injection vials false Inferred relationship Existential restriction modifier
Octreotide 30mg powder and solvent for suspension for injection vials 1 vial Has VMP Octreotide 30mg powder and solvent for suspension for injection vials true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Olatuton 30mg powder and solvent for prolonged-release suspension for injection vials (Teva UK Ltd) 1 vial Is a True Octreotide 30mg powder and solvent for suspension for injection vials 1 vial Inferred relationship Existential restriction modifier
Sandostatin LAR 30mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) 1 vial Is a True Octreotide 30mg powder and solvent for suspension for injection vials 1 vial Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start